UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054330
Receipt number R000062064
Scientific Title Research on nano- and microplastics contained in thrombi of cardiogenic cerebral embolism.
Date of disclosure of the study information 2024/05/07
Last modified on 2025/08/13 15:33:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research on nano- and microplastics contained in thrombi of cardiogenic cerebral embolism.

Acronym

Research on nano- and microplastics contained in thrombi of cardiogenic cerebral embolism.

Scientific Title

Research on nano- and microplastics contained in thrombi of cardiogenic cerebral embolism.

Scientific Title:Acronym

Research on nano- and microplastics contained in thrombi of cardiogenic cerebral embolism.

Region

Japan


Condition

Condition

cerebral infarction

Classification by specialty

Medicine in general Neurology Neurosurgery
Laboratory medicine Emergency medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To identify the presence of nano- and microplastics within embolised thrombi in patients with cardiogenic cerebral embolism.

Basic objectives2

Others

Basic objectives -Others

Chemical analysis of nano- and microplastics within embolised thrombi in patients with cardiogenic cerebral embolism.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Presence of plastic within the thrombus

Key secondary outcomes

Presence of other foreign materials within the thrombus (e.g. vinyl chloride)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Inclusion criteria.
Patients who meet the following criteria
1) Patients who have undergone mechanical thrombectomy due to cardiogenic cerebral embolism and the thrombus has been retrieved
2) Patients who have given consent to participate in the study (in person or by a substitute).

Key exclusion criteria

Exclusion Criteria.
Patients judged by two physicians to be unfit to participate in the study

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Yuya
Middle name
Last name Kobayashi

Organization

Ina Central Hospital

Division name

Neurology

Zip code

3968555

Address

Koshirokubo 1313-1, Ina

TEL

0265-72-3121

Email

juriruri@inahp.jp


Public contact

Name of contact person

1st name Yuya
Middle name
Last name Kobayashi

Organization

Ina Central Hospital

Division name

Neurology

Zip code

3968555

Address

Koshirokubo 1313-1, Ina

TEL

0265723121

Homepage URL


Email

juriruri@inahp.jp


Sponsor or person

Institute

Ina Central Hospital

Institute

Department

Personal name



Funding Source

Organization

Ina Central Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ina Central Hospital

Address

1313-1, Koshirokubo, Ina

Tel

0265723121

Email

info@inahp.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 05 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Suspended

Date of protocol fixation

2024 Year 05 Month 07 Day

Date of IRB

2024 Year 05 Month 07 Day

Anticipated trial start date

2024 Year 05 Month 07 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None.


Management information

Registered date

2024 Year 05 Month 07 Day

Last modified on

2025 Year 08 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062064